Evaluation of the effectiveness of robotic gait training and gait-focused physical therapy programs for children and youth with cerebral palsy: a mixed methods RCT by Lesley Wiart et al.
STUDY PROTOCOL Open Access
Evaluation of the effectiveness of robotic
gait training and gait-focused physical
therapy programs for children and youth
with cerebral palsy: a mixed methods RCT
Lesley Wiart1,2*, Rhonda J. Rosychuk3,4 and F. Virginia Wright5,6
Abstract
Background: Robot assisted gait training (RAGT) is considered to be a promising approach for improving
gait-related gross motor function of children and youth with cerebral palsy. However, RAGT has yet to be
empirically demonstrated to be effective. This knowledge gap is particularly salient given the strong interest in this
intensive therapy, the high cost of the technology, and the requirement for specialized rehabilitation centre resources.
Methods: This is a research protocol describing a prospective, multi-centre, concurrent mixed methods study
comprised of a randomized controlled trial (RCT) and an interpretive descriptive qualitative design. It is a mixed
methods study designed to determine the relative effectiveness of three physical therapy treatment conditions
(i.e., RAGT, a functional physical therapy program conducted over-ground (fPT), and RAGT + fPT) on gait related motor
skills of ambulatory children with cerebral palsy. Children with cerebral palsy aged 5–18 years who are ambulatory
(Gross Motor Function Classification System Levels II and III) will be randomly allocated to one of four treatment
conditions: 1) RAGT, 2) fPT, 3) RAGT and fPT combined, or 4) a maintenance therapy only control group. The qualitative
component will explicate child and parent experiences with the interventions, provide insight into the values that
underlie their therapy goals, and assist with interpretation of the results of the RCT.
Discussion: n/a.
Trial Registration: NCT02391324 Registered March 12, 2015.
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Background
Cerebral palsy is the most common cause of childhood
physical disability, affecting 2.0–2.5 in 1000 children [1].
It represents a group of disorders of movement and pos-
ture with impairments (e.g., muscle weakness, decreased
selective motor control, alterations in muscle tone, and
impaired postural control) that collectively affect func-
tional mobility. Methods of mobility are highly variable
in children with cerebral palsy. Approximately 65 % of
children with cerebral palsy use minimal or no assistive
devices (leg braces, walkers, and/or wheelchairs) to walk
(i.e., Gross Motor Function Classification System [GMFCS]
Levels I and II) [2] while those in GMFCS Levels III - V re-
quire varying degrees of bracing, walkers, or wheelchairs
for mobility. Walking abilities can change during the life
course; young adults who were ambulatory as children
may lose the ability to walk in early adulthood due to joint
pain and walking inefficiency [3].
Walking has well-recognized physiological and func-
tional benefits including prevention of muscle contrac-
tures [4], maintenance of bone density [5], and enhanced
cardiovascular fitness [6]. Effective mobility, which can
include ambulation or the use of assistive technology such
as powered wheelchairs, confers psychological benefits by
fostering children’s abilities to interact with peers and
* Correspondence: lwiart@ualberta.ca
1Department of Physical Therapy, Faculty of Rehabilitation Medicine,
University of Alberta, 2-60 Corbett Hall, Edmonton, Alberta T5G 2G4, Canada
2Glenrose Rehabilitation Hospital, Edmonton, Alberta, Canada
Full list of author information is available at the end of the article
© 2016 Wiart et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Wiart et al. BMC Neurology  (2016) 16:86 
DOI 10.1186/s12883-016-0582-7
explore their environments [7]. Walking is often empha-
sized because of the dominant societal beliefs about the
symbolic value of walking that is associated with normalcy
and reduction of the social stigma of disability [8].
Partial bodyweight support treadmill training (PBWSTT)
has recently received attention to improve walking patterns
and endurance of children with cerebral palsy [9]. This
training facilitates repeated, partially controlled step-taking
with a sling giving body weight support to allow greater
freedom of movement. Repeated active movement is
aligned with motor learning theory currently popular in
rehabilitation practice as a means of inducing neuroplastic
changes in the brain [10]. Motor learning approaches
emphasize movements that involve affected neural net-
works for motor control through high intensity practice of
motor tasks [10], feedback on performance through trial
and error, and active engagement of the child/adult in
producing and refining movement [11]. There is some
evidence that PBWSTT may promote improvements in
temporal aspects of gait, walking speed, and gross motor
abilities in children in GMFCS Levels II to IV [12]. How-
ever, it is labour intensive since therapists need to provide
extensive physical support including assistance with the
reciprocal leg movements. This limitation has sparked
international interest in the potential of robot assisted gait
training (RAGT) devices as a better approach to gait train-
ing in people with neurologic conditions.
RAGT devices such as the Lokomat® support an adult
or child upright on a treadmill while using robotics to
move his/her legs to simulate walking. The robotic de-
vice facilitates inter-limb co-ordination and gait cycle
timing and provides variable degrees of body weight
support and guidance, both of which can be decreased
as the child progresses. The adjustable weight support
allows the child to train at various walking speeds [13].
The biofeedback and virtual reality system (using an ava-
tar that reflects force and movement generated by the
child) gives a motivational environment with real-time
feedback on force and position. RAGT is also purported
to be more cost-effective than PBWSTT as far as
personnel and labour [14] due to lower need for manual
work by therapists. Early research evaluating the use of
RAGT devices (usually the Lokomat®) in adults post
stroke or spinal cord injury seemed promising [15], how-
ever recent RCTs have not found RAGT to be more
effective than regular, gait-focussed physiotherapy [9].
There have only been a few studies evaluating the effect-
iveness of RAGT with children and youth with cerebral
palsy. Initial research was conducted with ambulatory
individuals aged 4 to 20 years with cerebral palsy. In these
small sample, one-group, pre-post intervention studies
[16–20] participants showed improvements in gross
motor skills (as measured by the Gross Motor Function
Measure [GMFM] [21]), gait velocity and endurance
[16, 22], and gains were maintained for 6 months [18].
Participants improved equally on the GMFM Stand and
Walk Dimensions (i.e., mean gains about 5 points in each
after 12 sessions given over 3 weeks), suggesting an added
effect on postural stability for standing skills [20]. Appre-
ciable changes in motor performance were achieved after
participation in a short but highly intensive Lokomat® pro-
gram (i.e., 3 to 4 weeks, total of 12 to 16 sessions) [20, 22].
GMFM Walk Dimension improvement was linked with
total distance and time walked on the Lokomat® (r = -0.75,
p < 0.001), [20] suggesting a dose dependency. However
the lack of a control group in these studies precludes firm
conclusions about the efficacy of RAGT. A recent small
RCT with 52 children with cerebral palsy (GMFCS II/III)
demonstrated no advantage of RAGT over a physical ther-
apy program for walking speed or range of motion [23],
however the authors cautioned against making firm con-
clusions due to several study limitations. Research in this
area is generally comprised of studies that are methodo-
logically weak (i.e., one group pre-post test designs, small
sample sizes that limit statistical power and often lack clear
descriptions of therapy protocols) [9]. Outcome measure-
ment is often limited to the GMFM, which, provides infor-
mation on foundational motor skills, but does not measure
impacts on functional abilities and participation.
Additional criticisms of RAGT include the inability of
current RAGT systems to replicate the real-world de-
mands of overground walking [9]. For example, visual
spatial and optical inputs differ and the consistent pace
of the device does not offer the opportunity for training
temporal aspects of gait (e.g., timing of hip flexion,
swing, knee extension). Individuals with cerebral palsy
may walk more effectively using deviations from the tim-
ing of typical gait patterns. The individual’s reliance on
the treadmill and/or robot to create the steps may be
too passive thus is not consistent with the ‘real world’
demands of walking. Finally, prolonged focus and ex-
treme efforts towards walking may take away from other
important childhood activities and may not be the most
efficient way to increase participation [24]. This line of
critical thinking requires therapists to be mindful about
the role of walking in cerebral palsy rehabilitation, to
seek a full understanding of the impact of walking ther-
apies, and to understand the values and perspectives of
families in regards to walking especially as new and po-
tentially compelling ‘high tech’ options become more
widely available.
Methods/Design
This trial is a concurrent, mixed methods study [25].
Specifically, the quantitative arm is a multi-centre RCT
with four groups (22 factorial design, i.e., RAGT ab-
sent/present, fPT absent/present) with two periods of
post-intervention assessments (immediate and
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3 months later) (See Fig. 1 for Consort flow diagram).
The RCT is linked with an interpretive descriptive [26]
qualitative study arm. Methods for the quantitative
and qualitative components are described separately.
Research questions
i) What is the comparative effectiveness of
RAGT and a functional therapy program
for improving gait-related motor skills of
ambulatory children and youth with
cerebral palsy?
ii) Does combining RAGT and functional
therapy result in greater improvements in
gait-related skills of ambulatory children and
youth with cerebral palsy than RAGT or
functional therapy alone?
iii)What are families’ experiences with
the interventions and perceptions of
outcomes, and what are the associated
implications for interpretation of the
RCT results and use of RAGT and
functional therapy?
Randomized controlled trial design
Inclusion criteria
1) Children with a diagnosis of cerebral palsy
2) GMFCS level II or III
3) Ages 5 to 18 years
4) Able to follow GMFM testing instructions, and to
participate in a minimum of 45 min of active PT
5) Able to reliably signal pain, fear and discomfort
using verbal or nonverbal signals
Fig. 1 Consort flow chart
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Exclusion criteria
1) Botulinum Toxin (Type A) injection < 4 months or
planned within next 6 months,
2) Knee flexion contracture > 10°
3) Knee valgus >40°
4) Hip subluxation > 40 % migration percentage
5) Orthopaedic surgery (soft tissue releases) within the
last 9 months
6) Lower limb bony surgery < 18 months
7) Severe spasticity that interferes with use of RAGT
device
8) Weight bearing restrictions
9) Seizure disorder not fully controlled by medication.
Sample size
The sample size of 144 children represents 9 children
per age group (<13y; 13 to 18y), GMFCS strata, and
intervention combination. An additional 16 participants
will be recruited to accommodate an estimated 10 %
drop out rate (144/.9) for a total of 160. The 10 % drop
out rate was based on the current 7 % drop out rate in
the feasibility trial conducted at Holland Bloorview.
Sample size calculations were based on pre- to post-
intervention change on the primary outcome (Gross
Motor Function Measure-66) (GMFM-66) [21] and a
two-factor factorial design (F tests). For the GMFM-66
change score, assuming a Type I Error of 0.05 and 36
patients per group, the study will have 85 % power to
detect an effect size of 0.25 for the RAGT group, 0.25
for the fPT group, and 0.25 for the interaction. Assum-
ing a standard deviation (SD) of subjects of 10, these ef-
fect sizes correspond to an actual SD among appropriate
means of 2.5. For the GMFM-66, Dimensions D and E,
mean change scores of 5.3 (SD = 5.6) and 5.9 (SD = 7.1)
have been reported after Lokomat® training [20] and 4.6
(SD = 7.1) for PT [27]. These numbers correspond to
effect sizes of 0.9 (GMFM Dimension D), 0.8 (GMFM
Dimension E) for the Lokomat®, and 0.6 (GMFM-66
score) for PT. However, a change of 3 points on the
GMFM-66 is considered a clinically important difference
[28]. Thus we have amplified our power to detect a small
effect size (0.25) among groups. PASS [29] was used to
calculate sample size. Recruitment will take place at
the three sites Holland Bloorview (Toronto, Canada),
Glenrose Rehabilitation Hospital (Edmonton, Canada) and
the Rehabilitation Institute of Chicago (Chicago, U.S.) over
a period of 4 years.
Randomization
Following the screening assessment, participants will be
randomly allocated to one of the four groups using
computer-generated random sequence with varied block
sizes to prevent randomization pattern prediction by
investigators and ensure balanced group sizes. Age (<13 y;
13 to 18 y), GMFCS level (II and III), and site (Holland
Bloorview, Glenrose Rehabilitation Hospital, Institute of
Chicago) will be used as stratification variables to ensure
group balance. The random sequence will be uploaded
into the RedCap randomization module [30].
Blinding
Physical therapist assessors will be blinded to group
allocation. The three site research assistants will email
an independent research assistant (not otherwise con-
nected with the trial) to obtain the group assignment
from the randomization module of a RedCap [30] data-
base (as per the randomization schedule) once the child’s
baseline assessment has been completed. Group assign-
ment will be conducted several days post initial assess-
ment (parent is informed by phone of the child’s group
allocation). The data analyst will be blinded to group
allocation. Blinding of child/parent to group is not pos-
sible given the nature of the interventions.
Treatment
There are three intervention groups: 1) RAGT, 2)
RAGT + fPT, 3) fPT, and 4) one maintenance therapy
control (CONT) arm. All three intervention groups will
receive two 50-min sessions per week, separated by 2 or
3 days conducted over 8–10 weeks. This protocol meets
the minimum recommended duration of 60 days for
intensive interventions (as determined in a meta-analysis
of PT treatments in cerebral palsy) [31]. In addition, 3
sessions per week may be very challenging for families
and therefore the planned intensity and duration is also
based on clinical feasibility.
The LOK and fPT sessions are built on current motor
learning theory principles [32] and scoring of extent of
their use (treatment fidelity) will be possible via use of
the Motor Learning Strategy Rating Scale (MLSRI-20)
[33] by an external PT assessor with videos from two
sessions per child (4th and 8th sessions) [32]. The prompt
scoring of the session video and review by the centre in-
vestigator will permit prompt feedback to the treating
PT if motor learning strategy use levels do not reach the
targeted minimum score of 40 %.
Children in all four groups may continue to participate
in ‘maintenance therapy’ (commonly done by children
with cerebral palsy between blocks of active therapy) if
they are doing so prior to the study. This may include
range of motion/stretching and basic isometric strength
home program as well as up to 10 min per day of exercise
bicycle or treadmill or general walking practice. Families
will be asked to discontinue other active therapy during
the trial.
At each site, pediatric physical therapists and physical
therapy assistants with expertise working with children
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with cerebral palsy will be trained to provide RAGT and
fPT intervention protocols. Each child will be assigned
to a treatment team of two PTs who will share responsi-
bility for the 8 to 10 week intervention phase. The use
of a collaborative two-member team is consistent with
current models of service delivery in which a physical
therapist and physical therapy assistant or second phys-
ical therapist share responsibility for a child’s treatment.
The team approach also permits maximum scheduling
flexibility for the families. Strict guidelines regarding the
approaches that may/may not be used have been devel-
oped for the fPT and RAGT interventions. Since all
three interventions are manualized as well as menu- and
goal-based, the consistency of treatment focus/content
between PTs is maximized. This is especially important
for the fPT intervention due to increased potential
for individual physical therapy variation given the wide
breadth of treatment options available.
Children in the RAGT and RAGT + fPT groups will
also be assigned a physical therapy assistant who will
attend each RAGT session to assist with set-up/exit of
the child in the Lokomat as well as with integrated use
of other equipment, e.g., balls, beanbags. The assistant
will not be required during the fPT sessions unless the
treating physical therapist determines that their help is
required for taller/heavier youth in GMFCS III to ensure
therapist and child safety of movement for some or all
intervention activities. The extent and duration of physical
therapy assistant involvement will be documented in the
child’s session log.
RAGT
Participants will have one fitting visit/acclimatization
session before the actual treatment sessions begin. Partici-
pants in the RAGT arm will receive two 50-min sessions
per week. The study manualized RAGT walking protocol
provides methods for progressing/tracking including a
5-min over ground walking session after RAGT to facili-
tate transfer of motor learning to usual walking devices
[9]. The first RAGT walk will be 20 min, increasing, as
able, to 45 min plus 5 min of over ground walking at the
end [15]. The goal-based RAGT program uses a standard-
ized approach to progressing body weight and guidance
support and includes upper body activities while walking
to encourage dual tasking and improved posture, and
motor imagery practice. All robot settings and activities
will be recorded in the session log.
fPT
Participants will have two 50-min sessions per week.
The manualized motor-learning based protocol forms
the basis for this intervention. Its focus is on balance
(a key issue for children with cerebral palsy that cannot be
addressed in the fully supportive RAGT device) and
multi-plane gait-based motor skills. Each weekly fPT ses-
sion will consist of 50 min of active treatment, a ‘dose’
equivalent to time spent in active treatment in the RAGT
arm. The treatment program is menu-based. The physical
therapist will choose areas that best link with the child’s
goals and abilities [34] and document these in the session
log. Techniques that focus exclusively on body structure
changes will be not be permitted (e.g., inhibitive casting,
kinesiotaping, functional electrical stimulation).
RAGT + fPT group protocol
Participants will alternate between RAGT and fPT ses-
sions for the duration of the 8 to 10 week intervention
phase. Sessions will consist of two sessions of RAGT
1 week alternating with two sessions of fPT the follow-
ing week. RAGT will always commence in week 1. The
fPT will build on motor learning principles because the
activities will allow the child to practice motor skills in a
variety of different activities. The fPT sessions will aug-
ment and build on the previous week’s RAGT work, and
set the stage for the following week’s RAGT sessions.
Techniques focusing on body function/structure changes
will be prohibited.
Monitoring co-interventions
Maintenance therapies such as home stretching and
strengthening routines can be continued for all four
groups throughout the study because these therapies
have questionable efficacy [35–37] and will likely be
equally used across all four groups as they are common
PT recommendations. Mobility-based active therapy
must be discontinued ≥ 2 weeks prior to baseline assess-
ment. Throughout the 8–10 week intervention period
and the 3-month follow-up period, parents of children
in all four groups will be asked to report about other
therapies received or physical activities participated in
during the week. Use of other gross motor interventions
will also be tracked by the treating physical therapists.
Outcomes
All study outcomes will be measured pre-/post-interven-
tion (< 10 days pre-intervention and post-completion),
and at 3 m follow-up (+/- 10 day window). Trained
pediatric physical therapists with pediatric experience
will be trained to conduct the assessments. Assessors
will be assigned to a child. While inter-rater reliability of
all of the selected measures is good to excellent, use of
the same assessor will support a smaller minimum de-
tectable change. This sensitivity is particularly important
since the sample size was based upon a small (but clinic-
ally important) effect size. Prior assessment data will not
be available to the assessor at the follow-up assessments.
Assessments will be video-recorded and a random sam-
ple of 20 % of the assessment’s video-recordings will be
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scored by an independent assessor who will not be aware
of assessment sequence order. This double scoring will
be done through the study to flag any scoring issues and
allow remedial action.
Primary outcome
The primary outcome measure is the GMFM-66 [21]. It
has strong validity and responsiveness with children with
cerebral palsy and has been used in prior RAGT studies.
The GMFM-66 evaluation will be limited to Dimensions
D (Stand) and E (Walk/Run/Jump).
Secondary outcomes
Secondary outcomes include higher level gross motor
functioning (the Challenge Module) [38] for children in
GMFCS level II, walking capacity [39, 40], gait quality
[41] individualized goal attainment scores [42, 43],
balance [44, 45], quality of movement [46], functional
abilities [47], physical activity levels, self-efficacy for
physical activity [48], participation (PEM-CY) [49], and
quality of life [50, 51]. A list of included outcomes and as-
sociated measures are included in Table 1.
Statistical analysis
Data will be described (e.g., means, standard deviations,
frequencies) for each intervention group and each strati-
fication variable. Graphical summaries will include mean
plots and boxplots. Change scores (post minus pre,
follow-up minus post) will be summarized for each out-
come. For each change score and outcome, an ANOVA
for the two-factor factorial design will test the effect of
each factor (RAGT, fPT) and their interaction (RAGT*fPT)
on mean change score. Confidence intervals (95 % CIs) will
be reported for the mean of each intervention group. Fur-
ther, mixed-effects multiple linear regression models will
be developed for each outcome with centre as a random
effect, centre by intervention as an interaction (to assess
centre effect), and other important variables (e.g., age and
GMFCS level) as covariates. Variables will be dropped
from the model one at a time if p > 0.05, and residual diag-
nostics will assess model fit. This modeling will allow us
to assess the effect of the interventions in the presence of
important variables that were not balanced across inter-
vention groups by randomization and also can easily deal
with incomplete observation times. All main analyses will
be based on intent-to-treat with secondary analyses of
those with >80 % adherence to their intervention. R [52]
will be used for statistical analysis by a data analyst
blinded to intervention group.
Data and Safety Monitoring (DSMB)
An independent DSMB will assess any reports of adverse
events and will recommend to the researchers if the trial
should continue, be modified or stopped. The DSMB will
consist of three representatives from Toronto, Edmonton
and Chicago. Teleconferences will be scheduled annually.
Interpretive description (Qualitative Component)
While RCTs are the gold standard for evaluating cause
and effect relationships between interventions and pa-
tient outcomes [53] there is growing recognition that a
broader paradigmatic view of research methodologies is
necessary since RCTs do not serve well in the analysis of
the complex descriptions of human perspectives and ex-
periences [54–57]. Knowing why interventions do or do
not work is as important as knowledge of effectiveness if
interventions are to be successfully transferred into ‘real
world’ clinical settings [53, 58]. Rich contextual informa-
tion from qualitative research can provide insight into
how patient values and previous occurrences affect their
experience with the interventions, their adherence to the
study protocols, their impressions about the importance
of the outcomes achieved, and the reasons why they
choose to participate or not in clinical trials [54–57].
The three objectives of the concurrent qualitative
component are to explicate:
1) Child and parent experiences with the trial
interventions and the values and previous
experiences that shape their perceptions.
2) The mobility related outcomes that are important to
families and factors that influence these views.
3) Child and family values, experiences and contextual
factors that influenced participation in the trial,
including the follow-up period.
Table 1 Outcome measures
Outcome Outcome measures
Gross motor abilities GMFM-66 (Dimensions D- Stand &
E – Walk/Run/Jump) [21]
Challenge Measure (GMFCS level II) [38]
and GMFM Dimensions D and E with
aids and orthoses (GMFCS III) [21]
Walking capacity/gait 1- [39] and 6-Minute Walk Test [40],
Bloorview Barefoot Gait Assessment
(scored from video) [41]
Individualized goal attainment Canadian Occupational Performance
Measure (COPM) [42] and Goal
Attainment Scale (GAS) [43]
Standing and Walking Balance Pediatric Balance Scale [44], Quality FM
(Stability from GMFM-66 video) [46],
Activities Balance Confidence Scale [45]
Functional abilities PEDI-CAT [47]
Physical Activity levels Accelerometry (5 days)
Physical Activity Self-efficacy Self-Efficacy for Physical Activity [48]
Participation Participation and Environment Measure
for Children and Youth (PEM‐CY) [49]
Quality of life KidScreen [50] and Students’ Life
Satisfaction Scale (SLSS) [51]
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Design
Interpretive description [59], a methodology designed
for conducting rigorous qualitative research within the
health professions, will be the framework for the qualita-
tive component of this study. Interpretive description is
focused on “generating new knowledge pertaining to the
subjective, experiential, tacit and patterned aspects of
human health experience… so that we have sufficient
contextual understanding to guide future decisions that
will apply evidence to the lives of real people” [26]. It
provides a ‘design logic model’ for qualitative studies so
that the results are meaningful and applicable to clinical
practice.
Sample selection
Since the goals of parents and children may differ [60]
and be informed by different values regarding the im-
portance of walking [61], both will participate. The in-
clusion of parents and children will allow us to gain a
greater understanding of family dynamics and shared
understandings [62] that affect their experiences in the
trial. We will invite a subset of child-parent dyads from
each of the active interventions in the RCT and seek
maximum variation in this purposive sample by ensuring
an equal number of children in the two age groups (i.e.,
under and over 13) and both GMFCS levels, as well as a
diversity of cultural and socioeconomic status (critical
for objective #2). We will recruit families from all three
sites since factors that affect trial participation may vary
between provinces and centres based in Canada and the
United States. In addition, parents of children who were
eligible but declined to participate in the RCT will be in-
vited to participate in the qualitative component to ad-
dress objective #3. The estimated sample size is based
on theoretical understanding of the complexity and vari-
ability of the data. We anticipate that a sample of 18
RCT participant child-parent dyads (6 dyads from each
site) and 3 parents from each site who declined partici-
pation in the RCT will be adequate to address the three
objectives of the qualitative component. Our estimate is
based on similar qualitative research with families with
children with cerebral palsy [63–65] and is considered to
be a relatively large sample for this type of research [26].
Data collection
Individual interviews with parents (and their children for
those in the RCT) will be conducted. Parents will par-
ticipate in 45–60 min semi-structured, individual inter-
views conducted by one member of the research team.
Participating parents of children in the RCT will be
interviewed at 2 points within the trial (Fig. 1): i) after
identifying their individualized goals, prior to receiving
the intervention, and ii) within 1 month of intervention
completion.
Children from the RCT will participate in individual
interviews at the end of their intervention. While inter-
viewing children can pose some logistical challenges, if
adapted techniques are employed, children have the
potential to share rich narratives [62, 66]. A customizable
“tool box” of age-appropriate child-friendly techniques
[61] including photographs and comic captioning, vi-
gnettes, and sentence starters will be used in a 30–45 min
semi-structured interview with the child without the par-
ent present. The use of “concrete materials” in interviews
with children has been found to improve the quality and
depth of the interview exchange [67].
Data management and analysis
Interviews will be digitally audio-recorded, transcribed
verbatim by a professional transcriptionist, de-identified
and imported into NVivo for data management. Data
sources will be digital recordings, transcribed text of all
interviews, and field notes created by the interviewers.
The data management strategy described by Knafl [68]
will be used to analyze the data. Two researchers will
collaboratively identify general coding categories. Tran-
scripts will be analyzed as they are transcribed to ensure
that the emerging results inform the concurrent theoret-
ical sampling and data collection process [69]. The resear-
chers will meet to establish consensus on the coding. Data
will be transferred to index cards and organized by general
codes. The two researchers will identify subthemes and
the RA will conduct the remaining coding of excerpts into
subthemes in NVivo [70]. This process is recom-
mended for interpretive descriptive studies [59] as it
involves immersion in the data prior to any specific
coding and emphasizes theorizing, synthesizing and
re-contextualizing [26]. Field notes will not be coded
but will aid data interpretation, as they will contain
interviewer impressions and observations during the
interviews.
Enhancing credibility
i) Methodological triangulation - The use of
multiple methodologies or data sources will add
rigor, depth, complexity and richness to any research
study [71]. The results of this concurrent qualitative
component will provide essential context and
meaning to the interpretation of the change scores
from the RCT.
ii) Maximal variation in sampling - Ensuring
variability on the factors that likely influence family
perspective such as child age, GMFCS level,
treatment condition and site will enhance credibility
of the data. Lack of attention to this variation may
result in inaccurate claims about groups that were
not included in the sample [72].
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iii)Audit trail – Recording of methodological decisions
and their rationale as made throughout the
qualitative study will let us include reasoning in the
final report so that the consumers can judge
adequacy of decision-making [26].
iv)Peer debriefing – A summary of the qualitative
data analysis process will be reviewed and discussed
by all members of the research team mid-analysis
stage (i.e., once general themes are identified) and
after identification of sub-themes. Team members
not involved directly in the analysis will be
encouraged to ask critical questions about
methods, decisions and interpretation to facilitate
reflection among the team members conducting
the analysis. Peer debriefing sessions will be
documented [53].
Discussion
It is critical to know if children with cerebral palsy bene-
fit from RAGT more than over-ground walking training
programs and maintenance therapy alone. The results of
this trial will provide important insight into the relative
effectiveness of RAGT and functional physical therapy.
We will measure a broad range of outcomes that could
potentially be affected by RAGT, and we anticipate that
the trial will provide information needed to guide clin-
ical practice related to RAGT for children with cerebral
palsy.
RAGT is currently used clinically at the Edmonton
and Chicago sites and is used only for research in
Toronto. We anticipate that we may encounter some
challenges at recruitment at the two sites where RAGT
is used clinically. Our primary concern is related to pos-
sibility of parents’ preference for clinical use of RAGT
over the possibility of being randomly allocated to a con-
trol group. To mitigate this risk, we may inform parents
of group allocation following the screening assessment
and then will allow some flexibility in the timing of the
baseline assessment. This flexibility will allow families to
schedule according to group allocation. They may decide
to access clinical RAGT after the control period and dur-
ing the summer months, when many families request
therapy. In addition, children in the control group will
be able to access their choice of therapy upon comple-
tion of the study to mitigate the risk of drop outs due to
allocation to the control group.
The qualitative component will enhance the interpret-
ability of the quantitative data through data triangulation
[73]. In addition, the inclusion of a qualitative compo-
nent in this RCT will serve three key purposes. Firstly, it
will provide insight into the subjective experience of
children and their parents with the trial interventions
and how their values regarding quality of gait and previ-
ous therapy may have shaped those experiences.
Understanding these experiences is highly relevant to
the implementation of gait-related interventions in clin-
ical practice to ensure that children and parents are en-
gaged, able and motivated to participate in therapy.
Research in this area is lacking.
Secondly, the qualitative findings will provide valuable
information about the outcomes of mobility interventions
that are important to families. While RAGT replicates a
‘typical’ gait pattern with the hope that this will transfer
into overground walking, some research suggests that
compensatory movement patterns may be more efficient
for individuals with cerebral palsy [74]. Indeed, there is a
lively philosophical debate regarding the assumption that
individuals with disabilities always strive to appear or feel
more ‘normal’ [75]. While dominant cultural views and
traditional approaches in pediatric rehabilitation have fo-
cused on quality of gait, many individuals with disabilities,
therapists and researchers insist that improved functional
abilities and participation in meaningful activities and
social roles are more important outcomes. These may be
achieved using alternate methods of mobility, atypical gait
patterns, or compensatory approach to rehabilitation.
Thus, in addition to understanding the impact of RAGT
impact on gait outcomes, functional mobility and partici-
pation in meaningful activities, it is important to elucidate
the factors that influence child and parent goals related to
mobility.
Finally, the qualitative component will allow us to exam-
ine reasons families chose to participate or not in the trial.
For example, previous research suggests that parents may
want to pursue sophisticated interventions for their chil-
dren because they align with their conceptualization of
good parenting and the importance of ‘doing something
[61]. It is also possible that contextual factors such as
challenges with travel, time commitment, and managing
family life or conflict with values around walking may
preclude some families’ participation. This information is
useful regarding the feasibility of implementing the inter-
ventions in clinical practice and for interpreting trial
outcomes.
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